Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?

Medicines Adaptive Pathways to Patients (MAPPs) seeks to foster access to novel beneficial treatments for the right patient groups at the earliest appropriate time in the product life‐span, in a sustainable fashion. We summarize the MAPPs engagement process and critical questions to be asked at each...

Full description

Saved in:
Bibliographic Details
Published in:Clin Pharmacol Ther
Main Authors: Eichler, Hans‐Georg, Bedlington, Nicola, Boudes, Mathieu, Bouvy, Jacoline C., Broekmans, André W., Cerreta, Francesca, Faulkner, Stuart D., Forda, Susan R., Joos, Angelika, Le Cam, Yann, Mayer, Mark H., Pirard, Vinciane, Corriol‐Rohou, Solange
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6585618/
https://ncbi.nlm.nih.gov/pubmed/29901216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1121
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items